Literature DB >> 11687735

Role of reactive oxygen species (ROS) in patients with erythema migrans, an early manifestation of Lyme borreliosis.

S A Pancewicz1, E Skrzydlewska, T Hermanowska-Szpakowicz, J M Zajkowska, M Kondrusik.   

Abstract

BACKGROUND: Lyme borreliosis is a tick-transmitted, chronic, zoogenous disease caused by Borrelia burgdorferi spirochete. The clinical picture of Lyme disease is characterized by the variety of tissue and organ involvement and differing severity of symptoms. One of the pathogenic symptoms of early Lyme disease is a skin lesion called erythema migrans.
MATERIAL AND METHODS: The purpose of our research was to estimate the parameters of the antioxidant system and the concentration of lipid peroxidation products in the plasma of patients with erythema migrans (EM). The parameters measured included the activity levels of superoxide dismutase (SOD) according to Sykes, gluthatione reductase (GSSG-R) according to Mize and Langdon, glutathione peroxidase (GSH-Px) according to Paglia and Valentine; the concentrations of malondialdehyde (MDA) were examined by means of a Bioxytech LPO-586 kit. The total sulphydryl groups (-SH) according to Ellman and reduced glutathione (GSH) were measured using a Bioxytech GSH-400 test in plasma samples collected from 20 patients with EM aged from 19 to 50, taken before (examination 1) and after (examination 2) therapy with amoxycycline. The control group consisted of 8 healthy people.
RESULTS: The results of our examinations prove that beta-lactamase antibiotic therapy brings non-enzymatic antioxidant parameters to control values, though the treatment causes no change in enzymatic antioxidant parameters, resulting in the further activation of free radicals.
CONCLUSIONS: In patients with Erythema migrans, the decreased capability to reduce lipid superoxidants leads to maintaining a high concentration of membrane lipid peroxidation products.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687735

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  6 in total

1.  Lipid peroxidation products as potential bioindicators of Lyme arthritis.

Authors:  W Łuczaj; A Moniuszko; M Rusak; S Pancewicz; J Zajkowska; E Skrzydlewska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-06       Impact factor: 3.267

Review 2.  Application of medical and analytical methods in Lyme borreliosis monitoring.

Authors:  Magdalena Ligor; Paweł Olszowy; Bogusław Buszewski
Journal:  Anal Bioanal Chem       Date:  2011-10-21       Impact factor: 4.142

3.  Microarray analyses of inflammation response of human dermal fibroblasts to different strains of Borrelia burgdorferi sensu stricto.

Authors:  Frédéric Schramm; Aurélie Kern; Cathy Barthel; Sophie Nadaud; Nicolas Meyer; Benoît Jaulhac; Nathalie Boulanger
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 4.  Redox Imbalance and Its Metabolic Consequences in Tick-Borne Diseases.

Authors:  Monika Groth; Elżbieta Skrzydlewska; Marta Dobrzyńska; Sławomir Pancewicz; Anna Moniuszko-Malinowska
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

5.  CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Authors:  Bikash Sahay; Rebeca L Patsey; Christian H Eggers; Juan C Salazar; Justin D Radolf; Timothy J Sellati
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

6.  Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library.

Authors:  Jie Feng; Megan Weitner; Wanliang Shi; Shuo Zhang; David Sullivan; Ying Zhang
Journal:  Antibiotics (Basel)       Date:  2015-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.